Targeting glycosylphosphatidylinositol (gpi) pathway proteins to treat ovarian cancer
AssigneeUniversity of Massachusetts
InventorsMichael R. GREEN, Alok K. MISHRA, Sunil K. MALONIA
Life of this patent
Estimating the term…
Abstract
Methods for treating an ovarian cancer involving inhibition of a glycosylphosphatidylinositol (GPI) pathway protein such as glycosylphosphatidylinositol anchor attachment 1 (GPAA1), phosphatidylinositol glycan anchor biosynthesis class K (PIGK), phosphatidylinositol glycan anchor biosynthesis class P (PIGP), phosphatidylinositol glycan anchor biosynthesis class T (PIGT), and phosphatidylinositol glycan anchor biosynthesis class U protein (PIGU).
Claims14
A method of treating ovarian cancer, the method comprising administering to a subject in need thereof an effective amount of an inhibitor of a glycosylphosphatidylinositol (GPI) pathway protein.
Dependencies are inferred from the claim text.